GSK Statistics
Total Valuation
GSK plc has a market cap or net worth of $69.22 billion. The enterprise value is $84.76 billion.
Important Dates
The last earnings date was Wednesday, October 30, 2024, before market open.
Earnings Date | Oct 30, 2024 |
Ex-Dividend Date | Nov 15, 2024 |
Share Statistics
GSK plc has 4.08 billion shares outstanding. The number of shares has increased by 0.71% in one year.
Current Share Class | n/a |
Shares Outstanding | 4.08B |
Shares Change (YoY) | +0.71% |
Shares Change (QoQ) | +0.46% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 3.95B |
Valuation Ratios
The trailing PE ratio is 20.57 and the forward PE ratio is 8.18.
PE Ratio | 20.57 |
Forward PE | 8.18 |
PS Ratio | n/a |
Forward PS | 2.12 |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | 8.99 |
P/OCF Ratio | 6.96 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 6.83, with an EV/FCF ratio of 11.01.
EV / Earnings | 25.19 |
EV / Sales | 2.02 |
EV / EBITDA | 6.83 |
EV / EBIT | 9.18 |
EV / FCF | 11.01 |
Financial Position
The company has a current ratio of 0.81, with a Debt / Equity ratio of 1.19.
Current Ratio | 0.81 |
Quick Ratio | 0.52 |
Debt / Equity | 1.19 |
Debt / EBITDA | 1.70 |
Debt / FCF | 2.80 |
Interest Coverage | 10.83 |
Financial Efficiency
Return on equity (ROE) is 21.85% and return on invested capital (ROIC) is 13.67%.
Return on Equity (ROE) | 21.85% |
Return on Assets (ROA) | 7.24% |
Return on Capital (ROIC) | 13.67% |
Revenue Per Employee | $597,707 |
Profits Per Employee | $47,933 |
Employee Count | 70,212 |
Asset Turnover | 0.53 |
Inventory Turnover | 1.52 |
Taxes
In the past 12 months, GSK plc has paid $596.43 million in taxes.
Income Tax | 596.43M |
Effective Tax Rate | 13.51% |
Stock Price Statistics
The stock price has decreased by -4.32% in the last 52 weeks. The beta is 0.33, so GSK plc's price volatility has been lower than the market average.
Beta (5Y) | 0.33 |
52-Week Price Change | -4.32% |
50-Day Moving Average | 37.17 |
200-Day Moving Average | 40.57 |
Relative Strength Index (RSI) | 45.81 |
Average Volume (20 Days) | 7,042,166 |
Short Selling Information
Short Interest | 23.52M |
Short Previous Month | 16.55M |
Short % of Shares Out | 1.15% |
Short % of Float | n/a |
Short Ratio (days to cover) | 3.32 |
Income Statement
In the last 12 months, GSK plc had revenue of $41.97 billion and earned $3.37 billion in profits. Earnings per share was $0.81.
Revenue | 41.97B |
Gross Profit | 30.38B |
Operating Income | 9.23B |
Pretax Income | 6.06B |
Net Income | 3.37B |
EBITDA | 12.41B |
EBIT | 9.23B |
Earnings Per Share (EPS) | $0.81 |
Full Income Statement Balance Sheet
The company has $4.31 billion in cash and $21.52 billion in debt, giving a net cash position of -$17.22 billion or -$4.22 per share.
Cash & Cash Equivalents | 4.31B |
Total Debt | 21.52B |
Net Cash | -17.22B |
Net Cash Per Share | -$4.22 |
Equity (Book Value) | 18.03B |
Book Value Per Share | 4.60 |
Working Capital | -5.58B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $9.95 billion and capital expenditures -$1.80 billion, giving a free cash flow of $7.70 billion.
Operating Cash Flow | 9.95B |
Capital Expenditures | -1.80B |
Free Cash Flow | 7.70B |
FCF Per Share | $1.89 |
Full Cash Flow Statement Margins
Gross margin is 72.39%, with operating and profit margins of 22.00% and 8.02%.
Gross Margin | 72.39% |
Operating Margin | 22.00% |
Pretax Margin | 10.52% |
Profit Margin | 8.02% |
EBITDA Margin | 29.56% |
EBIT Margin | 22.00% |
FCF Margin | 19.81% |
Dividends & Yields
This stock pays an annual dividend of $1.56, which amounts to a dividend yield of 4.45%.
Dividend Per Share | $1.56 |
Dividend Yield | 4.45% |
Dividend Growth (YoY) | 12.10% |
Years of Dividend Growth | n/a |
Payout Ratio | 190.97% |
Buyback Yield | -0.71% |
Shareholder Yield | 3.82% |
Earnings Yield | 4.86% |
FCF Yield | 11.12% |
Dividend Details Analyst Forecast
The average price target for GSK plc is $45.50, which is 30.17% higher than the current price. The consensus rating is "Hold".
Price Target | $45.50 |
Price Target Difference | 30.17% |
Analyst Consensus | Hold |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | 4.43% |
EPS Growth Forecast (5Y) | 10.13% |
Stock Forecasts Stock Splits
The last stock split was on July 19, 2022. It was a reverse split with a ratio of 0.8:1.
Last Split Date | Jul 19, 2022 |
Split Type | Reverse |
Split Ratio | 0.8:1 |
Scores
GSK plc has an Altman Z-Score of 1.91 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.91 |
Piotroski F-Score | 6 |